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Experimental, epidemiologic and clinical studies have pro-
vided strong evidence that physical exercise has beneﬁcial effects
on multiple physiological variables affecting cardiovascular health
(lipoprotein levels, rest blood pressure and heart rate, carbohy-
drate tolerance, neurohormonal activity). Regular exercise has
been shown to slow the progression of cardiovascular disease and
to reduce cardiovascular morbidity and mortality. More recently,
exercise-induced increases in blood ﬂow and shear stress have
been observed to enhance vascular function and structure. By
increasing the release of nitric oxide and prostacyclin, shear
stress augments endothelium-dependent vasodilation and inhibits
multiple processes involved in atherogenesis and restenosis. In
this review we discuss the underlying mechanisms by which
exercise-induced blood ﬂow and shear stress exert their salutary
effects on cardiovascular remodeling.
(J Am Coll Cardiol 1996;28:1652–60)
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The notion that regular aerobic exercise reduces cardiovascu-
lar morbidity and mortality in the general population as well as
in patients with coronary artery disease is strongly supported
by evidence derived from epidemiologic studies (1–3). Physi-
cally active people also experience fewer clinical manifesta-
tions of coronary artery disease than do less active men and
women (4). By contrast, sedentary life-style has been identiﬁed
as a risk factor for development of coronary artery disease, and
there is a strong correlation between physical inactivity and
cardiovascular mortality (3,5). Although vigorous physical ex-
ertion is a precipitating factor for myocardial infarction, this
adverse outcome is usually incurred by persons who otherwise
lead a sedentary existence (6,7). Consequently, daily physical
aerobic activity is considered an effective component of both
primary and secondary prevention of cardiovascular events
(8,9). The purpose of this review is to provide an overview of
the mechanisms by which exercise exerts its salutary effect on
cardiovascular function and structure. We will focus on the
role of exercise-induced increases in blood ﬂow to modulate
vascular tone and structure.
Salutary Effects of Exercise
There are numerous salutary effects of exercise that con-
tribute to the reduction of vascular events in physically active
men and women (Fig. 1). Exercise is associated with beneﬁcial
changes in body fat percentage (10,11), lipoprotein proﬁle
(11), carbohydrate tolerance and insulin sensitivity (12), neu-
rohormonal release (catecholamine, renin, aldosterone, vaso-
pressin) (13) and blood pressure (14,15). Furthermore, there is
substantial evidence garnered from clinical and animal studies
that regular aerobic exercise can alter vessel structure. The
progression of coronary lesions can be inhibited and, in some
cases, regression of disease can be observed in patients who
modify their cardiovascular risk factors and engage in regular
aerobic exercise (16–19). It is estimated that an average of
1,500 kcal/week must be spent on leisure time physical activity
to halt progression of disease, whereas regression is only
observed in patients expending an average of 2,200 kcal/week.
This latter degree of energy expenditure is equivalent to 5 to
6 h/week of moderate exertion in the form of aerobic exercise
(20). Experimental studies and clinical observations (21–28)
indicate that there is a signiﬁcant correlation between regular
physical exercise and an increase in the lumen diameter of
coronary arteries. Men who reportedly had a physically active
occupation (24) or a generally active life-style (25,26) had
larger than expected coronary arteries. Frequently cited is the
case report based on the autopsy of the marathon runner
Clarence De Mar, whose epicardial vessels were found to be
“two or three times the normal size” (25). Mann and col-
leagues (26) found that vigorously active Masai tribesmen who
died of noncardiovascular causes and had no clinical evidence
of coronary artery disease had as much coronary atheroscle-
rosis at autopsy as American men but had patent arterial
lumens because of the large size of their epicardial vessels.
Quantitative angiographic studies (17,19) have revealed that
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exercise programs reduce the progression of coronary artery
disease. Finally, vigorous physical exercise is associated with
changes in the structure of collateral vessels and the microvas-
culature. Although the conclusions drawn from animal studies
are not completely congruent, the weight of the evidence
(21,22,29–33) indicates that intensive aerobic exercise pro-
motes collateral formation or expansion of the microvascula-
ture, or both. However, exercise training has not been shown to
increase coronary collateral formation in humans (32,33).
In addition to changes in vascular structure, changes in
vascular tone may be induced by long-term regular exercise.
Haskell and colleagues (27) used quantitative coronary angiog-
raphy to study vascular reactivity in ultra-distance runners and
sedentary age- and gender-matched men and women. Al-
though there were no differences between groups in basal
diameter of the epicardial coronary arteries, when sublingual
nitroglycerin was administered, the arteries of the marathoners
showed a 200% greater increase in vasodilation than did those
of the sedentary group. These data (27) provide evidence for
exercise-induced alterations of the structure or reactivity, or
both, of the vessel wall. Exercise may also induce changes in
lumen diameter in patients after coronary angioplasty. Indeed,
patients randomized to a 12-week intervention program con-
sisting of daily exercise after balloon angioplasty enjoyed a
signiﬁcantly lower rate of restenosis than patients in the
control group (34).
Collectively, these ﬁndings support the hypothesis that
regular aerobic exercise induces salutary changes in vessel
structure and reactivity. However, these studies leave unan-
swered many questions regarding the molecular mechanisms of
exercise-induced vascular remodeling and reactivity. Recent
investigations have provided some clues into the cellular and
molecular mechanisms by which alterations in blood ﬂow and
shear stress may affect vascular structure and reactivity.
Flow-Mediated Vasodilation
The two principal forces acting on the blood vessel are
pulsatile stretch and shear stress. Pulsatile stretch is deter-
mined by ﬂuctuation in arterial pressure and is a force exerted
at a vector that is perpendicular to the longitudinal axis of the
vessel. Shear stress is determined by blood ﬂow and is a tractive
force exerted at a vector that is parallel to the long axis of the
vessel. The preponderance of scientiﬁc data suggests that
exercise-induced increases in endothelial shear stress has
beneﬁcial effects on vascular structure and reactivity. Our
focus is on the mechanism by which exercise-induced changes
in ﬂow may alter vascular reactivity and structure.
Physical exercise increases intracoronary blood ﬂow, result-
ing in a vasodilation of the epicardial coronary arteries that is
largely dependent on the integrity of the endothelium (35–38).
The essential role of the endothelium in exercise-induced
ﬂow-mediated vasodilation has been conﬁrmed in exercising
dogs (39). Whereas exercise-induced epicardial coronary vaso-
dilation was observed during treadmill running, marked vaso-
constriction was found during treadmill exercise up to 6 days
after balloon denudation of the endothelium. This ﬂow-
mediated vasodilation was proportional to the shear stress
induced by blood ﬂow and was independent of changes in
pressure within the lumen (40,41).
Flow-mediated vasodilation is largely due to the release of
endothelium-derived relaxing factor (EDRF) (38,42,43), al-
though in some circulations prostacyclin (43–45) or an
endothelium-derived hyperpolarizing factor may contribute
(46). Endothelial cells produce bursts of prostacyclin in re-
sponse to sudden increases in shear stress. This action may
indicate that the shear stress gradient, rather than the absolute
level of shear stress, may be the more relevant physiologic
stimulus (47). Of the factors released by the endothelium in
Abbreviations and Acronyms
ATP  adenosine triphosphate
Ca2  calcium ion
EDRF  endothelium-derived relaxing factor
MAP  mitogen-activated protein
mRNA  messenger ribonucleic acid
NO  nitric oxide
SSRE  shear stress responsive elements
TGF-beta1  transforming growth factor-beta1
PDGF-beta  platelet-derived growth factor-beta
VCAM-1  vascular cell adhesion molecule-1
Figure 1. Diagram indicating the mechanisms by
which exercise may inhibit atherogenesis and modulate
the course of coronary artery disease.
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response to ﬂow, EDRF is the most potent vasodilator. EDRF
was ﬁrst described in 1980 by Furchgott and Zawadzki (48) and
is now known to be nitric oxide (NO) (49,50). NO is derived
from the metabolism of L-arginine to L-citrulline by NO
synthase (51). Like other nitrovasodilators, NO exerts its effect
on vascular smooth muscle by activating soluble guanylate
cyclase to produce cyclic guanosine monophosphate. In addi-
tion, NO may stimulate calcium (Ca2) activated potassium
channels, thereby inducing hyperpolarization and relaxation of
vascular smooth muscle (52).
A dynamic balance between endothelium-derived vasodi-
lating (e.g., adenosine triphosphate [ATP], substance P) and
vasoconstricting (e.g., endothelin-1) factors contributes to the
regulation of vascular tone by shear stress. Shear stress induces
the release of ATP or substance P, or both, from endothelial
cells of numerous vascular beds (53,54). Both ATP and
substance P stimulate speciﬁc receptors on the endothelium to
release NO. In addition to inducing the release of ATP,
increases in ﬂow deliver more circulating ATP to the endothe-
lial surface, overwhelming ectopyrases that degrade the nucle-
otide. The result is that more ATP reaches its purinergic
receptors to stimulate endothelial release of NO (55,56).
Physiologic levels of ﬂow tend to inhibit the release of
endothelin-1 (57–61), a potent peptide vasoconstrictor. The
release of endothelin-1 is known to be inhibited by NO (62).
However, the effect of shear stress on the release of
endothelin-1 from endothelial cells is complex. Physiologic
levels of shear stress induce a transient increase in
endothelin-1 messenger ribonucleic acid (mRNA) expression
and peptide release, which is followed by a signiﬁcant suppres-
sion (59,61,63). In human umbilical vein endothelial cells, low
levels of shear stress stimulate the release of endothelin-1,
whereas high levels inhibit its release (57).
In addition to its vasoconstrictor effects, endothelin-1 is a
potent mitogenic agent (64). This effect of endothelin-1 is
further potentiated by other growth stimulating substances
such as angiotensin II, platelet-derived growth factor beta
(PDGF-beta) and insulin (65,66). Therefore endothelin-1 may
critically contribute to the induction of coronary vasospasm as
well as to the proliferative processes involved in vascular
pathology.
Bicycle ergometry performed by healthy subjects did not
lead to any signiﬁcant changes in endothelin-1 levels, but
plasma endothelin-1 concentrations increased in patients with
coronary atherosclerosis (67). When these patients received
supplementation of NO with oral nitrates during the 72 h
before exercise testing, the exercise-induced increase in
endothelin-1 was attenuated. This observation indicates that
the reduced activity of endothelium-derived NO in atheroscle-
rotic blood vessels may play an important role in the exercise-
induced increase of endothelin-1 secretion in humans. An
imbalance of these endogenous vasoactive agents may explain
in part the association between myocardial infarction and
preceding vigorous physical exercise in subjects at risk who did
not exercise on a regular basis (6,7).
Mechanotransduction of
Flow-Mediated Vasodilation
Recent investigations have shed light on the mechanisms by
which the endothelium senses and transduces the stimulus of
ﬂow. An endothelial potassium channel is known to be acti-
vated by ﬂow (68). The mechanisms by which ion channels are
activated by ﬂow remain obscure, but they probably involve
shear stress-mediated deformation of cytoskeletal elements
(69). The activity of an endothelial potassium channel also
appears to be required for the ﬂow-induced (but not receptor-
mediated) release of NO from vascular segments or cultured
endothelial cells (38,70). This unique signal transduction path-
way is coupled to a pertussis toxin–sensitive G protein (71).
Intriguingly, this same signal transduction pathway is involved
in the ﬂow-induced transcription of transforming growth
factor-beta1 (TGF-beta1) (72). Thus, the initial response to an
increase in ﬂow (vasodilation) and the later response (change
in vascular structure) may share a common mechanotrans-
ducer.
These observations dovetail nicely with work from other
groups indicating that ﬂow increases Ca2 inﬂux (55,56,73) in
endothelial cells, an effect that is necessary for the synthesis
and release of NO. By hyperpolarizing the endothelial cell, the
ﬂow-activated potassium channel maintains the electrochemi-
cal gradient for Ca2 entry. The ﬂow-induced changes in Ca2
ﬂux may also be modulated by vasoactive agents such as ATP
(56). Flow-induced changes in ion channel activity may also be
regulated by the activity of kinases (e.g., mitogen-activated
protein (MAP) kinase) that are associated with cytoskeletal
elements responding to mechanical deformation. MAP kinases
are members of a well characterized protein kinase system, and
they have been shown to mediate cell responses to physical
forces such as osmotic stress (74) and stretch (75,76). However,
the pathways leading to activation of MAP kinase by physical
forces are not well understood.
There is recent evidence, that ﬂow may activate dual
signal-transduction pathways in endothelial cells. As described
earlier, one pathway is Ca2 dependent and involves increases
in intracellular Ca2 and activation of phospholipase C
(77,78). A Ca2-independent pathway may also contribute to
ﬂow-mediated activation of NO synthase. Ayajiki et al. (79)
found that ﬂow-stimulated NO release from the perfused
rabbit iliac artery has a biphasic nature. An initial Ca2-
dependent phase is followed by a phase of sustained NO
release that is Ca2 independent. This pathway appears to
require the activity of the sodium-hydrogen ion exchanger as
well as activation of protein kinase C and tyrosine kinase.
A kininergic mechanism may contribute to ﬂow-mediated
vasodilation. Flow may induce the release of bradykinin from
endothelial cells (80). Subsequently bradykinin may stimulate
its respective receptors on the endothelial cell to induce the
release of NO. Indeed, Groves et al. (81) recently addressed
this issue using quantitative coronary angiography to study the
ﬂow-mediated vasodilation in the epicardial coronary arteries
of subjects without coronary artery disease. They found that
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the bradykinin receptor antagonist Hoe 140 signiﬁcantly inhib-
ited ﬂow-mediated vasodilation but did not affect receptor-
mediated endothelium-dependent vasodilation in these sub-
jects. The study indicates that bradykinin may play an
autocrine role in ﬂow-mediated vasodilation.
Chronic Effects of Flow on
Vascular Reactivity
Can regular exercise alter vascular reactivity so as to
enhance vasodilation? Evidence is accumulating that regular
exercise can exert beneﬁcial effects on vascular reactivity, and
that these salutary changes are due to exercise-induced in-
creases in blood ﬂow. Long-term changes in ﬂow exert their
effects on endothelium-dependent vasodilation by modulating
the expression of NO synthase. The expression of mRNA for
NO synthase is up-regulated in cultured endothelial cells
exposed to laminar shear stress (82). Similarly, the magnitude
and nature of shear stress have a major impact on endothelial
cell NO synthesis (83). In cultured human umbilical vein
endothelial cells, laminar shear stress dose dependently up-
regulates NO synthesis, whereas turbulent shear stress has no
effect on the NO synthase pathway.
The changes in endothelial reactivity and NO synthase
expression seen with sustained increases in ﬂow are similar to
changes in endothelial behavior in vessels exposed for long
periods to intermittent increases in ﬂow (as with exercise).
Exercise-induced changes in vascular reactivity have been
observed in the coronary arteries of dogs after 8 weeks of
exercise (84). In patients with congestive heart failure, there is
an impaired ﬂow-mediated vasodilation of the brachial artery;
exercise training enhances this NO-mediated vasodilation (85).
These studies suggest that exercise-induced changes in blood
ﬂow alter vascular responsiveness. These ﬁndings are consis-
tent with recent observations from animal studies in which
short-term (86) and long-term (37,43,86) exercise increased
the mRNA expression of NO synthase, augmented NO activity
and enhanced endothelium-dependent vasodilation in coro-
nary arteries.
The mechanism by which ﬂow augments the expression of
NO synthase involves shear stress responsive elements (SSRE)
within the promoter region of the gene. The consensus se-
quence for the SSRE in the NO synthase promoter is
GAGACC, a putative transcription factor binding site that is
common to the promoter regions of many endothelial genes
that are responsive to shear stress including tissue plasminogen
activator, intercellular adhesion molecule, TGF-beta1, PDGF-
beta, and endothelin-1 (87,88). There are almost certainly
other cis-acting transcriptional regulatory elements and pro-
teins responsive to shear stress.
Chronic increases in blood ﬂow may also effect the elabo-
ration of prostacyclin. This may be particularly important in
circulations (such as skeletal muscle microvasculature) where
this prostanoid plays a larger role in ﬂow-mediated vasodila-
tion. Koller et al. (43) demonstrated in a rat model that the
sensitivity of gracilis muscle arterioles to wall shear stress was
up-regulated after short-term daily exercise, which resulted in
an augmented dilator response, probably due to increased
release of both endothelium-derived NO and prostacyclin.
Hecker et al. (89) observed continuous release of NO and
prostacyclin from the endothelium that was enhanced by an
increase in shear stress; the release of both vasodilators
counteracts neurogenic and myogenic vasoconstriction in vivo.
However, in human conduit arteries the contribution of pros-
tacyclin to ﬂow-mediated vasodilation is negligible, as NO
plays the major role (90).
The effects of ﬂow on vascular reactivity may have clinical
implications. It has been reported that individual patients with
coronary artery disease who regularly participate in intensive
physical exercise may show a signiﬁcant increase in maximal
rate-pressure product (an equivalent of myocardial oxygen
consumption) (91,92) or a decrease in exercise-induced myo-
cardial ischemia (as documented by thallium-201 scintigraphy),
or both, despite progression of coronary artery disease (17,19).
These observations may be explained in part by improvements
in vascular reactivity.
Mechanisms of Flow-Induced Alterations in
Vascular Structure
Can regular exercise effect vascular structure and promote
patency? The answer appears to be in the afﬁrmative, and
exercise-induced changes in blood ﬂow probably contribute to
this beneﬁcial effect. Vessels are capable of signiﬁcant remod-
eling in response to long-term changes in ﬂow. In various
animal models, vigorous endurance-type exercise training en-
larges the diameter of coronary arteries, and this effect is
independent of the exercise-induced hypertrophy of the end-
organ supplied by the vessel (22,23,28,93). In the canine
carotid artery, increases in blood ﬂow enlarge vessel diameter;
this change is associated with an increased rate of protein
turnover (94), providing evidence that structural adaptation
occurs in response to increased ﬂow.
Just as ﬂow-mediated vasodilation is endothelium depen-
dent, so too is ﬂow-mediated vascular remodeling. Langille
and O’Donnell (95) found that a long-term decrease in ﬂow
through the rat carotid artery causes the vessel caliber to
diminish in response to structural modiﬁcation of the arterial
wall. This vascular remodeling is abolished by removal of the
endothelium. Conversely, increasing blood ﬂow or shear stress
by an arteriovenous shunt causes structural changes that result
in a larger vessel (94,96). This increase in vessel diameter in the
setting of increased ﬂow reduces endothelial shear stress
toward the preshunt value. This ﬁnding implies that the
endothelium may be the transducer (and generate the para-
crine effectors) of the hemodynamic signal that triggers vascu-
lar remodeling in response to ﬂow. The endothelial mecha-
nisms mediating these structural effects remain undeﬁned. It
appears plausible that the endothelium induces changes in
vessel structure by producing mediators that regulate cell
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growth, extracellular matrix production and proteolysis. Flow
modulates the endothelial elaboration of multiple paracrine
factors that may affect vascular growth including NO (38),
PDGF-beta (97), TGF-beta1 (72), tissue plasminogen activator
(98) prostacyclin (43–45,47,99) and endothelin-1 (57–61).
Alterations of Flow Response in Disease
In the normal human coronary circulation, increased blood
ﬂow is associated with vasodilation of epicardial vessels
(100,101). By contrast, a paradoxic vasoconstriction to in-
creased blood ﬂow has been documented in atherosclerotic
coronary arteries. The dilation of diseased vessels in response
to nitroglycerin (endothelium-independent vasodilation) but
not to increases in ﬂow implicates endothelial dysfunction as
the underlying cause of the altered vasomotion (100). Even in
subjects without angiographic evidence of atherosclerosis, ex-
posure to coronary risk factors is associated with inhibition of
endothelium-dependent vasodilation (102). Progressive im-
pairment of endothelial vasodilator function in human coro-
nary arteries becomes manifest even at the early stages of
atherosclerosis. In patients with hypercholesterolemia but an-
giographically normal coronary arteries, there is selective
impairment of acetylcholine-induced (but not ﬂow-induced)
endothelium-dependent vasodilation; with more evidence of
disease, there is loss of ﬂow responsiveness as well. A strong
correlation has been reported between total serum cholesterol
and the impairment of endothelium-mediated increases in
coronary blood ﬂow (103).
Flow-mediated vasodilation of the brachial artery is often
impaired before the onset of clinical evidence of atherosclero-
sis, and this impairment was manifested even in children as
young as 7 years of age with hypercholesterolemia (104).
Subsequent studies (105) revealed that loss of ﬂow-mediated
endothelium-dependent dilation in the brachial artery pre-
cedes the clinical onset of vascular disease; this dysfunction is
associated with the same risk factors (hypercholesterolemia,
hypertension, diabetes mellitus, tobacco exposure) known to
predispose to atherosclerosis and its complications in later life.
Hemodynamic Determinants of Lesion Site
Atherosclerotic lesions develop mainly near branches, bi-
furcations and bends, all areas of low shear stress, where there
is separation from unidirectional laminar blood ﬂow, reversal
of ﬂow and turbulence (96,106–113). Low shear stress is
associated with increased wall thickening (96,110,113–115) and
accelerated lumen narrowing in moderately diseased human
coronary arteries (116). There is a continuous inverse relation
between shear stress and rate of lumen narrowing (116).
Whereas low shear stress is associated with atherogenesis and
disease progression, regions of moderate to high shear stress
are relatively spared of intimal thickening as long as ﬂow
remains unidirectional and axially aligned (113). Animal stud-
ies and clinical trials (117–119) have documented a direct
correlation between graft ﬂow and long-term graft patency;
reduced vascular runoff after percutaneous transluminal angio-
plasty is predictive of restenosis. Flow-induced release of
paracrine modulators of vascular growth (e.g., NO and pros-
tacyclin) may explain the effect of laminar ﬂow to inhibit
restenosis and atherogenesis.
Increased ﬂow causes an increase in endothelial shear stress
that is associated with enlargement of nonatherosclerotic
arteries, as seen in arteriovenous ﬁstulas (94,96). The same
phenomenon may occur in atherosclerosis. As plaque impinges
on the vessel lumen, endothelial shear stress increases, given
the same rate of ﬂow. This might be expected to trigger the
same remodeling response that occurs in other settings of
increased shear stress. Indeed, in human coronary arteries
lumen narrowing of up to 40% may be fully compensated by
enlargement of the vessel, thus preventing the stenosis from
becoming functionally relevant (120). By contrast, areas of low
shear stress or disturbed ﬂow are vulnerable to atherogenesis.
The mechanism by which low or disturbed ﬂow accelerates
atherogenesis and restenosis is probably multifactorial. In
areas of disturbed ﬂow, recirculation prolongs contact of
atherogenic particles with the endothelium. In these areas of
low shear stress, platelets and monocytes are more likely to
adhere to the vessel wall (121). These local differences in shear
stress may explain why there is an increased rate of atheroscle-
rosis progression among different vessels within the same
patient (and even different segments within the same vessel)
despite exposure to the same lipoprotein concentrations (116).
Finally, areas of low shear stress may be more prone to
intimal lesion formation, because in these areas the endothe-
lium may produce less vasoprotective factors, such as NO and
prostacyclin. Considering the beneﬁcial effects of NO and
prostacyclin, it could be speculated that the spatial distribution
of atherosclerotic plaques in areas of low shear stress may in
part be explained by a reduced elaboration of NO and
prostacyclin at these sites. Indeed, endothelium-dependent
vasodilation is reduced at bifurcations in human coronary
arteries before angiographically observable disease develops
(122).
Flow-Released NO Opposes Atherogenesis
Animal studies (37,43,86,90) indicate that an exercise inter-
vention may reverse endothelial dysfunction. Preliminary stud-
ies from Clarkson et al. (122a) suggest that this observation
also holds true for humans; young smoking army recruits
manifested partial improvement in ﬂow-mediated vasodilation
of the brachial artery after several weeks of regular exercise as
part of their military training. These alterations in ﬂow-
induced release of NO probably extend to the endothelial
elaboration of other paracrine factors. The beneﬁcial effects of
exercise on endothelium-dependent vasodilation may have
signiﬁcant consequences for vascular structure as well as
vascular reactivity. In addition to its effects on vasomotion, NO
is known to antagonize key processes involved in atherogene-
sis, including monocyte adherence and chemotaxis (123),
platelet adherence and aggregation (124–126) and vascular
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smooth muscle proliferation (127). Enhancement of NO activ-
ity in hypercholesterolemic rabbits reduces monocyte adher-
ence and accumulation, whereas inhibition of NO activity
enhances endothelial adhesiveness for monocytes and in-
creases the extent of lesion formation (128–130).
The mechanisms by which physiologic levels of shear stress
inhibit atherogenesis are beginning to be understood. Expo-
sure of endothelial cells to ﬂuid ﬂow in vitro reduces their
adhesiveness for monocytes (131–134). This effect of ﬂow is
mediated by alterations in signal transduction of adhesion, as
well as by changes in the expression and activation of endo-
thelial adhesion molecules and chemokines (132–137). Flow-
stimulated release of NO rapidly inhibits endothelial adhesive-
ness for monocytes, with a time course (in minutes) that is
most consistent with an effect on adhesion signaling. However,
with longer time courses, ﬂow-induced NO also affects expres-
sion of adhesion molecules. Speciﬁcally, exposure of endothe-
lial cells to ﬂuid ﬂow for 2 h suppresses lipoprotein- or
cytokine-induced expression of vascular cell adhesion
molecule-1 (VCAM-1) (133). This effect is abrogated by NO
synthase antagonists, indicating that endothelium-derived NO
participates in the regulation by ﬂow of VCAM-1 expression.
NO modulates VCAM-1 expression by regulating redox-
sensitive transcriptional pathways (136,138). Oxidant stress
activates transcriptional factors (e.g., nuclear factor kappa-B),
leading to the expression of oxidant responsive genes such as
VCAM-1 and monocyte chemotactic protein-1 (139). NO may
exert a counterregulatory role by inhibiting the local genera-
tion of oxygen-derived free radicals, thereby reducing oxidant
stress. Preliminary evidence from our group (133) reveals that
ﬂuid ﬂow reduces the elaboration of superoxide anion by
endothelial cells in an NO-dependent manner. This ﬁnding is
consistent with previous observations that NO inhibits the
activity of the oxidative enzyme NADPH oxidase (140). Fur-
thermore, ﬂuid ﬂow enhances the expression of superoxide
dismutase, which scavenges superoxide anion (141).
Flow-stimulated release of prostacyclin may also modulate
processes that alter vascular architecture (43,45,47,99). Pros-
tacyclin, as well as its analogues, inhibits the uptake of
cholesterol esters into macrophages and vascular smooth mus-
cle cells (142,143). Prostacyclin also inhibits the adherence of
platelets and neutrophils to the endothelium, which may
explain the observations that administration of exogenous
prostacyclin analogues reduces the size of experimentally
induced infarcts (144–146) and the extent of arrhythmias
(147). Accordingly, it is conceivable that exercise-induced
increases in prostacyclin release may produce beneﬁcial effects
not only through vasodilation, but also by inhibiting platelet
and neutrophil adherence. The elaboration of prostacyclin is
reduced in atherosclerosis. Vessel wall segments involved by
atheromatous plaques do not produce prostacyclin (148). This
ﬁnding is consistent with observations in animal models that
reveal that prostacyclin production by the vessel wall is abol-
ished by hypercholesterolemia and deendothelialization (149).
Disease-induced alterations in the elaboration of this factor
may contribute to the impairment of vascular reactivity and
remodeling in response to ﬂow.
Conclusions
There is now abundant epidemiologic and experimental
evidence indicating that physical exercise slows the progression
of vascular disease and reduces cardiovascular morbidity and
mortality. The mechanisms of this effect include beneﬁcial
changes in lipoprotein proﬁle, rest blood pressure and heart
rate, carbohydrate tolerance, neurohormonal activity and
exercise-induced increases in blood ﬂow. Exercise-induced
increases in blood ﬂow appear to have direct effects on vas-
cular function and structure. Flow enhances endothelium-
dependent vasodilation by increasing the vascular expression
of NO synthase and by enhancing the release of NO and
prostacyclin. NO and prostacyclin inhibit multiple processes
involved in atherogenesis and restenosis (including generation
of superoxide anion, adherence of monocytes, aggregation of
platelets and proliferation of vascular smooth muscle). In
addition to NO and prostacyclin, ﬂow modulates the expres-
sion of a panoply of paracrine substances, including endothe-
lial growth factors, matrix modulators, adhesion molecules,
chemokines and regulators of blood ﬂuidity, all of which may
participate in the beneﬁcial effects of exercise-induced vascular
remodeling and reactivity. Several fundamental basic and
clinical questions remain unanswered. Only a few elements of
the endothelial signal transduction pathways mediating the
response to shear stress have been identiﬁed. This is also true
for the transcriptional mechanisms by which shear stress
induces gene expression. A role for these cellular mechanisms
in the clinical effects of exercise has not been established. It is
not known how much exercise is needed to restore endothelial
function, how long these effects might persist after exercise and
to what degree these effects contribute to the salutary effects of
exercise on cardiovascular health. The investigation of these
questions is likely to lead to novel approaches to pharmaco-
therapy and exercise rehabilitation for the patient with coro-
nary artery disease.
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